Stay informed with the latest stock performance, financial data, and market activity for Aprea Therapeutics (NASDAQ: APRE). As we advance our mission to develop next-generation cancer therapies, we remain committed to delivering long-term value to our shareholders through scientific excellence and operational integrity.
| Date Requested | Open Price | Day High | Day Low | Closing Price | Volume | Split Adjustment Factor |
|---|---|---|---|---|---|---|
| June 8, 2026 | $0.75 | $0.77 | $0.73 | $0.73 | 56,649 | 1:1 |
| June 9, 2026 | $0.73 | $0.77 | $0.70 | $0.74 | 91,211 | 1:1 |
| June 10, 2026 | $0.74 | $0.79 | $0.74 | $0.75 | 78,665 | 1:1 |
NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which may have occurred for this security since the date shown. The Split Adjustment Factor is a cumulative factor which encapsulates all splits since the date shown. The closing price is not necessarily indicative of future price performance.
Minimum 15 minutes delayed. Source: LSEG